index - Myopathies inflammatoires & thérapies innovantes ciblées

Dernières publications

Chiffres clés

123 Publications avec texte intégral

Open Access

53 %

Mots clés

Skeletal muscle Inclusion body myositis B-lymphocyte Multidisciplinarity Data integration Anti-agalsidase antibodies Muscle Outcome measures IMNM AAV vector Acute Kidney Injury/epidemiology/etiology Auto-antibodies Biomarker Adeno-associated virus vector Sphingosine-1-phosphate Cancer Myositis Animals Adult Antisynthétase Aldosterone Adeno-associated vector Interferon Autoimmunity Amyotrophic lateral sclerosis Male AAV vectors AAV Autoimmune diseases Antiphospholipid syndrome IBM Inflammatory myopathy Anti-drug antibodies Amyotrophy AAV humoral immunity Cytokines Dermatomyositis Antisynthetase Myositis and muscle disease Anti-interleukin-6 Auto-immunité Biopsy Adverse drug reactions Biomarkers Fabry disease Dependovirus/genetics/immunology DM Lysosomal storage diseases Auto‐antibodies Active Anti‐mitochondrial antibodies Anti-synthetase syndrome Adolescence Female Middle Aged Myopathy Aldostérone Anti-Mi2 Anémie hémolytique Idiopathic inflammatory myopathies Anticorps anti-agalsidase Arthritis Antisynthetase syndrome COVID-19 Autoantibody Deep immune profiling Adjudication Antibody responses Abnormal movement Inflammation Aged Adeno-associated virus Cardio-oncology Immune checkpoint inhibitors Humans Prognosis Anti-MDA5 autoantibodies Myocarditis B cell homeostasis Anti-IgE IgG Bioelectrical impedance analysis AAV antibody Systems biology Pharmacology Immunotherapy Assisted communication devices Biomarqueurs Agalsidase Anticorps spécifique des myosites Case reports Gene therapy Mass cytometry Antibodies Interstitial lung disease Polymyositis Acid-alpha-glucosidase Analyses multidimensionnelles Machine learning Inborn errors of metabolism Autoantibodies